RATIONALE
By virtue of Republic Act No. 3720, otherwise known as the “Foods, Drugs and Devices, and Cosmetics Act”, as amended, and Republic Act No. 9711, otherwise known as the “Food and Drug Administration (FDA) Act of 2009”, and its Implementing Rules and Regulations, it was made the policy of the state that health products made available in the country, including drugs or medicines, are safe, effective, and of good quality. While Republic Act No. 11032 otherwise knownas the Ease of Doing Business and Efficient Government Service Delivery Act of 2018, through facilitated registration pathways are envisioned to reduce workload allocated for administrative and technical evaluation by recognizing to certain defined degrees the assessments conducted by reference drug regulatory agencies.
Read more:-> Administrative Order 2020-0045